Vaccine composition for use against influenza
US-9220767-B2 · Dec 29, 2015 · US
Herpesvirus of turkeys vectored vaccine against avian influenza in poultry
US8986987B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8986987-B2 |
| Application number | US-201113879822-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 17, 2011 |
| Priority date | Oct 18, 2010 |
| Publication date | Mar 24, 2015 |
| Grant date | Mar 24, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present application applies to the field of veterinary vaccines, in particular of vaccines for poultry against avian influenza. The vaccine is based on a recombinant viral vector expressing the haemagglutinin protein of an influenza virus, wherein the vector is herpes virus of turkeys (HVT) and the haemagglutinin gene is driven by a glycoprotein B gene promoter from a mammalian herpesvirus. A vaccine comprising this HVT+HA vector can be used to induce a protective immune response against avian influenza in poultry, and to reduce the spread of AIV. The invention also relates to methods, uses, and vaccines involving the HVT+HA vector.
First claim
Opening claim text (preview).
The invention claimed is: 1. A recombinant herpes virus of turkeys (HVT) vector comprising a heterologous nucleic acid, wherein said heterologous nucleic acid comprises an extended mammalian herpesvirus glycoprotein B (gB) gene promoter operably linked to a nucleotide sequence which encodes an influenza virus (IV) hemagglutinin (HA) protein, wherein the extended mammalian herpesvirus gB gene promoter comprises the nucleotide sequence as in SEQ ID NO: 2. 2. The r…
Assignees
Inventors
Classifications
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8986987B2 cover?
- The present application applies to the field of veterinary vaccines, in particular of vaccines for poultry against avian influenza. The vaccine is based on a recombinant viral vector expressing the haemagglutinin protein of an influenza virus, wherein the vector is herpes virus of turkeys (HVT) and the haemagglutinin gene is driven by a glycoprotein B gene promoter from a mammalian herpesvirus.…
- Who is the assignee on this patent?
- Sondermeijer Paulus Jacobus Antonius, Verstegen Iwan, Intervet Inc
- What technology area does this patent fall under?
- Primary CPC classification A61K39/145. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Mar 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).